BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 17804554)

  • 1. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis.
    Tanaka A; Nezu S; Uegaki S; Mikami M; Okuyama S; Kawamura N; Aiso M; Gershwin ME; Takahashi S; Selmi C; Takikawa H
    Ann N Y Acad Sci; 2007 Jun; 1107():259-70. PubMed ID: 17804554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
    Reynoso-Paz S; Leung PS; Van De Water J; Tanaka A; Munoz S; Bass N; Lindor K; Donald PJ; Coppel RL; Ansari AA; Gershwin ME
    Hepatology; 2000 Jan; 31(1):24-9. PubMed ID: 10613723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
    Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis.
    Tsuneyama K; Van De Water J; Van Thiel D; Coppel R; Ruebner B; Nakanuma Y; Dickson ER; Gershwin ME
    Hepatology; 1995 Nov; 22(5):1440-6. PubMed ID: 7590661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC.
    Fukushima N; Nalbandian G; Van De Water J; White K; Ansari AA; Leung P; Kenny T; Kamita SG; Hammock BD; Coppel RL; Stevenson F; Ishibashi H; Gershwin ME
    Hepatology; 2002 Dec; 36(6):1383-92. PubMed ID: 12447863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis.
    Miyakawa H; Tanaka A; Selmi C; Hosoya N; Mataki N; Kikuchi K; Kato T; Arai J; Goto T; Gershwin ME
    Clin Dev Immunol; 2006; 13(2-4):289-94. PubMed ID: 17162370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis.
    Ikuno N; Mackay IR; Jois J; Omagari K; Rowley MJ
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1390-4. PubMed ID: 11851838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA class antibodies to 2-oxo-acid dehydrogenase complex are not predictive markers of histopathological progression in primary biliary cirrhosis.
    Omagari K; Kadokawa Y; Nakamura M; Akazawa S; Ohba K; Ohnita K; Mizuta Y; Daikoku M; Yatsuhashi H; Ishibashi H; Kohno S
    Autoimmunity; 2006 Mar; 39(2):107-12. PubMed ID: 16698666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunity and primary biliary cirrhosis: presence of antimitochondrial antibodies in urine.
    Tanaka A; Nalbandian G; Leung PS; Benson GD; Munoz S; Findor JA; Branch AD; Coppel RL; Ansari AA; Gershwin ME
    Hepatology; 2000 Nov; 32(5):910-5. PubMed ID: 11050038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of antimitochondrial antibodies in health adults.
    Mattalia A; Quaranta S; Leung PS; Bauducci M; Van de Water J; Calvo PL; Danielle F; Rizzetto M; Ansari A; Coppel RL; Rosina F; Gershwin ME
    Hepatology; 1998 Mar; 27(3):656-61. PubMed ID: 9500690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.
    Bogdanos DP; Baum H; Okamoto M; Montalto P; Sharma UC; Rigopoulou EI; Vlachogiannakos J; Ma Y; Burroughs AK; Vergani D
    Hepatology; 2005 Aug; 42(2):458-65. PubMed ID: 16025495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
    Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
    Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis.
    Masuda J; Omagari K; Ohba K; Hazama H; Kadokawa Y; Kinoshita H; Hayashida K; Hayashida K; Ishibashi H; Nakanuma Y; Kohno S
    Dig Dis Sci; 2003 May; 48(5):932-8. PubMed ID: 12772793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis.
    Malmborg AC; Shultz DB; Luton F; Mostov KE; Richly E; Leung PS; Benson GD; Ansari AA; Coppel RL; Gershwin ME; Van de Water J
    J Autoimmun; 1998 Oct; 11(5):573-80. PubMed ID: 9802945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
    Chen QY; Rowley MJ; Mackay IR
    Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
    Zhang FK; Jia JD; Wang BE
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):288-91. PubMed ID: 15138128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.
    Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL
    Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis.
    Harada K; Sudo Y; Kono N; Ozaki S; Tsuneyama K; Gershwin ME; Nakanuma Y
    Hepatology; 1999 Jul; 30(1):36-45. PubMed ID: 10385636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens.
    Miyakawa H; Tanaka A; Kikuchi K; Matsushita M; Kitazawa E; Kawaguchi N; Fujikawa H; Gershwin ME
    Hepatology; 2001 Aug; 34(2):243-8. PubMed ID: 11481607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
    Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
    Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.